Growth Hormone Diseases

  • Jarrah Ali Al-Tubaikh


The human growth hormone (GH) is a polypeptide consisting of 188 amino acids and having a molecular weight of 21,500. GH from other species shares partial sequences of amino acids in common with human GH (e.g., bovine GH). These partial sequences consist of active cores, which are pharmacologically active. Thus, it may be not necessary to synthesize the entire bovine GH molecule to yield an actively working substance in humans.


Growth Hormone Pituitary Adenoma Growth Hormone Insufficiency Cardiac Myxoma Sertoli Cell Tumor 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

For Further Reading

  1. 1.
    Daughaday WH et al The pituitary in disorders of growth. Dis Mon. 1962;8:1–47CrossRefGoogle Scholar
  2. 2.
    Kaplan SA. Human growth hormone. Dis Mon. 1968;14:1–33CrossRefGoogle Scholar
  3. 3.
    Frohman LA. Diseases of hypothalamic releasing factors. Dis Mon. 1976;22:1–37PubMedCrossRefGoogle Scholar
  4. 4.
    Ron E et al Acromegaly and gastrointestinal cancer. Cancer. 1991;68:1673–77PubMedCrossRefGoogle Scholar
  5. 5.
    Tani Y et al Locking of the metacarpophalangeal joints in a patient with acromegaly. Skelet Radiol. 1999;28:655–7CrossRefGoogle Scholar
  6. 6.
    Fisher MS. An unusual bone change in acromegaly. Skelet Radiol. 1978;3:177–8CrossRefGoogle Scholar
  7. 7.
    Doppman JL et al Cushing syndrome due to primary pig-mented nodular adrenocortical disease: findings at CT and MR imaging. Radiology. 1989;172:415–20PubMedGoogle Scholar
  8. 8.
    Elster AD. Imaging of the sella: anatomy and pathology. Semin Ultrasound CT MRI. 1993;14:182–94CrossRefGoogle Scholar
  9. 9.
    Wyszynski DF. Dysmorphology in the Bible and the Talmud. Teratology. 2001;64:221–5PubMedCrossRefGoogle Scholar
  10. 10.
    Laron Z. Growth hormone insensitivity (Laron syndrome). Rev Endocr Metab Disord. 2002;3:347–55PubMedCrossRefGoogle Scholar
  11. 11.
    Laron Z. Laron syndrome (primary growth hormone resistance or insensitivity): the personal experience 1958–2003. J Clin Endocrinol Metab. 2004;89:1031–44PubMedCrossRefGoogle Scholar
  12. 12.
    Kornerich L et al Laron syndrome abnormalities: spinal stenosis, Os odontoideum, degenerative changes of the atlanto-odontoid joint, and small oropharynx. AJNR Am J Neuroradiol. 2002;23:625–31Google Scholar
  13. 13.
    Chakraborty PP et al Laron's syndrome in two siblings. Indian J Pediatr. 2007;74:870–1PubMedCrossRefGoogle Scholar
  14. 14.
    Jacobs P. Van Buchem disease. Postgrad Med J. 1977;53:497–506PubMedCrossRefGoogle Scholar
  15. 15.
    Boikos SA et al Pituitary pathology in patients with carney complex: growth-hormone producing hyperplasia or tumors and their association with other abnormalities. Pituitary. 2006;9:203–9PubMedCrossRefGoogle Scholar
  16. 16.
    Vandersteen A et al Cutaneous signs are important in the diagnosis of rare neoplasia syndrome Carney complex. Eur J Pediatr (2009);168:1401–1404PubMedCrossRefGoogle Scholar
  17. 17.
    Mateus C et al Heterogeneity of skin manifestations in Patients with Carney syndrome. J Am Acad Dermatol. 2008;59:801–10PubMedCrossRefGoogle Scholar
  18. 18.
    Cazabat L et al PRKAR1A mutations in primary pigmented nodular adrenocortical disease. Pituitary. 2006;9:211–9PubMedCrossRefGoogle Scholar
  19. 19.
    Haupt HA. Anabolic steroids and growth hormones. Am J Sport Med. 1993;21:468CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2010

Authors and Affiliations

  • Jarrah Ali Al-Tubaikh

There are no affiliations available

Personalised recommendations